Acumen Pharmaceuticals, Inc. (ABOS) released Loss for its full year of -$102.33 million
The company's earnings totaled -$102.33 million, or -$1.71 per share. This compares with -$52.37 million, or -$1.08 per share, last year.
Acumen Pharmaceuticals, Inc. earnings at a glance (GAAP) :
-Earnings: -$102.33 Mln. vs. -$52.37 Mln. last year.
-EPS: -$1.71 vs. -$1.08 last year.
For comments and feedback: editorial@rttnews.com